PIGRET assay can detect mutagenicity of ethyl methanesulfonate much earlier than RBC Pig-a assay

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 811, Issue , 2016, Pages 102-105

  Itoh, Satoru ^a   Hattori, Chiharu ^a   Nakayama, Shiho ^a   Hanamoto, Akiharu ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

In vivo mutation assay; Pig a gene; Red blood cells; Reticulocytes

Indexed keywords

MESYLIC ACID ETHYL ESTER; MEMBRANE PROTEIN; MUTAGENIC AGENT; PHOSPHATIDYLINOSITOL GLYCAN-CLASS A PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD; COMPARATIVE STUDY; CONTROLLED STUDY; ERYTHROCYTE; FLOW CYTOMETRY; GENE MUTATION; HUMIDITY; LIGHT DARK CYCLE; MALE; MUTAGENICITY; NONHUMAN; PIG A ASSAY; PIGRET ASSAY; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; RETICULOCYTE; RETICULOCYTE COUNT; VALIDITY; ANIMAL; DRUG EFFECTS; GENETICS; MUTAGEN TESTING; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALS; ERYTHROCYTES; ETHYL METHANESULFONATE; MALE; MEMBRANE PROTEINS; MUTAGENICITY TESTS; MUTAGENS; RATS; RATS, SPRAGUE-DAWLEY; RETICULOCYTES;

EID: 84949657012     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2015.11.010     Document Type: Article

References (14)

1. [1] Dobrovolsky, V.N., Miura, D., Heflich, R.H., Dertinger, S.D., The in vivo Pig-a gene mutation assay, a potential tool for regulatory safety assessment. Environ. Mol. Mutagen. 51 (2010), 825–835.
2. [2] Gollapudia, B.B., Lynch, A.M., Heflich, R.H., Dertinger, S.D., Dobrovolsky, V.N., Froetschl, R., Horibata, K., Kenyon, M.O., Kimoto, T., Lovell, D.P., Stankowski, L.F. Jr., White, P.A., Witt, K.L., Tanir, J.Y., The in vivo Pig-a assay: a report of the International Workshop On Genotoxicity Testing (IWGT) workgroup. Mutat. Res. 783 (2015), 23–35.
3. [3] OECD Guidelines for the Testing of Chemicals, Test No. 488: Transgenic Rodent Somatic and Germ Cell Gene Mutation Assays, 26 July 2013.
4. [4] Dertinger, S.D., Phonethepswath, S., Franklin, D., Weller, P., Torous, D.K., Bryce, S.M., Avlasevich, S., Bemis, J.C., Hyrien, O., Palis, J., MacGregor, J.T., Integration of mutation and chromosomal damage endpoints into 28-day repeat dose toxicology studies. Toxicol. Sci. 115 (2010), 401–411.
5. [5] Kimoto, T., Horibata, K., Chikura, S., Hashimoto, K., Itoh, S., Sanada, H., Muto, S., Uno, Y., Yamada, M., Honma, M., Interlaboratory trial of the rat Pig-a mutation assay using an erythroid maker HIS49 antibody. Mutat. Res. 755 (2013), 126–134.
6. [6] Itoh, S., Nagata, M., Hattori, C., Takasaki, W., In vivo mutagenicity of ethyl methanesulfonate detected by Pig-a and PIGRET assays. Genes Environ. 36 (2014), 174–178.
7. [7] Kimoto, T., et al. The PIGRET assay, a method for measuring Pig-a gene mutation in reticulocytes, is reliable as a short-term in vivo genotoxicity test: summary of the MMS/JEMS-collaborative study across 16 laboratoriesusing 24 chemicals. Mutat. Res. 811 (2016), 3–15.
8. [8] Kimoto, T., Chikura, S., Suzuki-Okada, K., Kobayashi, X.m., Itano, Y., Miura, D., Kasahara, Y., Effective use of the Pig-a gene mutation assay for mutagenicity screening: measuring CD59-deficient red blood cells in rats treated with genotoxic chemicals. J. Toxicol. Sci. 37 (2012), 943–955.
9. [9] Kimoto, T., Chikura, S., Suzuki, K., Kobayashi, X.m., Itano, Y., Horibata, K., Honma, M., Dobrovolsky, V.N., Heflich, R.H., Miura, D., Kasahara, Y., Further development of the rat Pig-a mutation assay: measuring rat Pig-a mutant bone marrow erythroids and a high throughput assay for mutant peripheral blood reticulocytes. Environ. Mol. Mutagen. 52 (2011), 774–783.
10. [10] Dobo, K.L., Fiedler, R.D., Gunther, W.C., Thiffeault, C.J., Cammerer, Z., Coffing, S.L., Shutsky, T., Schuler, M., Defining EMS and ENU dose–response relationships using the Pig-a mutation assay in rats. Mutat. Res. 725 (2011), 13–21.
11. [11] Gunther, W.C., Coffing, S.L., Dickinson, D.A., Engel, M.E., Fiedler, R.D., O'Lone, S.D., Sanok, K.E., Thiffeault, C.J., Shutsky, T.J., Schuler, M.J., Dobo, K.L., Evaluation of the Pig-a, micronucleus, and comet assay endpoints in a 28-day study with ethyl methanesulfonate. Environ. Mol. Mutagen. 55 (2014), 492–499.
12. [12] Itoh, S., Shimada, H., Bone marrow and liver mutagenesis in lacZ transgenic mice treated with hexavalent chromium. Mutat. Res. 412 (1998), 63–67.
13. [13] Miura, D., Dobrovolsky, V.N., Kimoto, T., Kasahara, Y., Heflich, R.H., Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. Mutat. Res. 677 (2009), 86–92.
14. [14] Kenyon, M.O., Coffing, S.L., Ackerman, J.I., Gunther, W.C., Dertinger, S.D., Criswell, K., Dobo, K.L., Compensatory erythropoiesis has no impact on the outcome of the in vivo Pig-a mutation assay in rats following treatment with the hemolytic agent 2-butoxyethanol. Mutagenesis 30 (2015), 325–334.